TrialInternational urology and nephrology2017

Addition of silymarin to renin-angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial.

Luminita Voroneanu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.